Proteomic characterization of Her2/neu-overexpressing breast cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Proteomic characterization of Her2/neu-overexpressing breast cancer cells

Published:2010-10-19 Issue:21 Volume:10 Page:3800-3810
ISSN:1615-9853
Container-title:PROTEOMICS
language:en
Short-container-title:Proteomics

Author:

Chen Hexin,Pimienta Genaro,Gu Yiben,Sun Xu,Hu Jianjun,Kim Min-Sik,Chaerkady Raghothama,Gucek Marjan,Cole Robert N.,Sukumar Saraswati,Pandey Akhilesh

Publisher

Wiley

Subject

Molecular Biology,Biochemistry

Reference46 articles.

1. The hallmarks of cancer;Hanahan;Cell,2000

2. EGF-ERBB signalling: towards the systems level;Citri;Nat. Rev. Mol. Cell. Biol.,2006

3. Breast cancer: when proteomics challenges biological complexity;Hondermarck;Mol. Cell. Proteomics,2003

4. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sorlie;Proc. Natl. Acad. Sci. USA,2001

5. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab;Cho;Nature,2003

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical support for tumor protein D52 as a cancer vaccine antigen;Human Vaccines & Immunotherapeutics;2023-10-30

2. HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment;npj Breast Cancer;2022-05-20

3. HIF-Dependent CKB Expression Promotes Breast Cancer Metastasis, Whereas Cyclocreatine Therapy Impairs Cellular Invasion and Improves Chemotherapy Efficacy;Cancers;2021-12-22

4. The Role of Omics Approaches to Characterize Molecular Mechanisms of Rare Ovarian Cancers: Recent Advances and Future Perspectives;Biomedicines;2021-10-15

5. HIF-dependent CKB expression promotes breast cancer metastasis, whereas cyclocreatine therapy impairs cellular invasion and improves chemotherapy efficacy;2021-09-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3